3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
17
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
14
Triple Negative Breast Neoplasms
12
Lung Neoplasms
12
Neoplasm Metastasis
11
Squamous Cell Carcinoma of Head and Neck
8
Ovarian Neoplasms
8
Fallopian Tube Neoplasms
7
Endometrial Neoplasms
7
Esophageal Neoplasms
5
Oropharyngeal Neoplasms
4
Neoplasms
4
Melanoma
4
Colorectal Neoplasms
4
Adenocarcinoma Of Esophagus
4
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Inflammatory Breast Neoplasms
2
Hypopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Gallbladder Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Brenner Tumor
2
Anatomic Stage II Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Adenocarcinoma
2
Interventions
Specimen Handling
5
Nivolumab
4
Magnetic Resonance Spectroscopy
4
cabozantinib
3
Gemcitabine
3
enfortumab vedotin
2
Ipilimumab
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
trastuzumab deruxtecan
1
relatlimab
1
pembrolizumab
1
eribulin
1
erdafitinib
1
avelumab
1
atezolizumab
1
Lenalidomide
1
Doxorubicin
1
Contrast Media
1
Cisplatin
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urethral Neoplasms
×
Taxes
×
90 days
×
Clear all
No trials found.